Australian CVD Risk Calculator
Iteration3 - ci-build

Australian CVD Risk Calculator - Local Development build (vIteration3) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions

## : Aus CVD Risk Lipid Modifying Medicine - JSON Representation

Draft as of 2025-05-19

Raw json | Download

    {
      "resourceType" : "ValueSet",
      "id" : "AusCVDRiskLipidModifyingMedicine-1",
      "text" : {
        "status" : "generated",
        "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: ValueSet AusCVDRiskLipidModifyingMedicine-1</b></p><a name=\"AusCVDRiskLipidModifyingMedicine-1\"> </a><a name=\"hcAusCVDRiskLipidModifyingMedicine-1\"> </a><a name=\"AusCVDRiskLipidModifyingMedicine-1-en-AU\"> </a><ul><li>Include codes from<a href=\"http://www.snomed.org/\"><code>http://snomed.info/sct</code></a> where constraint  = ( ( ((^929360061000036106|MP | AND &lt;&lt; (108600003 |Atorvastatin| OR 96307003 |Fluvastatin| OR 96305006 |Pravastatin| OR 96304005 |Simvastatin| OR 319982006 |Acipimox-containing product| OR 319937007 |Bezafibrate-containing product| OR 72824008 |Colestyramine| OR 77035009 |Clofibrate| OR 66971004 |Colestipol-containing product| OR 408041006 |Ezetimibe| OR 35282000 |Gemfibrozil| OR 63639004 |Nicotinic acid|)) OR (&lt;&lt;^929360071000036103|MPUU | AND &lt;&lt; (108600003 |Atorvastatin| OR 96307003 |Fluvastatin| OR 96305006 |Pravastatin| OR 96304005 |Simvastatin| OR 319982006 |Acipimox-containing product| OR 319937007 |Bezafibrate-containing product| OR 72824008 |Colestyramine| OR 77035009 |Clofibrate| OR 66971004 |Colestipol-containing product| OR 408041006 |Ezetimibe| OR 35282000 |Gemfibrozil| OR 63639004 |Nicotinic acid|)) OR (&lt;&lt;^ 929360081000036101|MPP Refset|: { 774160008 | Contains clinical drug (attribute) | = &lt;&lt; (108600003 |Atorvastatin| OR 96307003 |Fluvastatin| OR 96305006 |Pravastatin| OR 96304005 |Simvastatin| OR 319982006 |Acipimox-containing product| OR 319937007 |Bezafibrate-containing product| OR 72824008 |Colestyramine| OR 77035009 |Clofibrate| OR 66971004 |Colestipol-containing product| OR 408041006 |Ezetimibe| OR 35282000 |Gemfibrozil| OR 63639004 |Nicotinic acid|) }) OR (( ( &lt;&lt;^929360071000036103|MPUU | AND &lt;&lt; (108600003 |Atorvastatin| OR 96307003 |Fluvastatin| OR 96305006 |Pravastatin| OR 96304005 |Simvastatin| OR 319982006 |Acipimox-containing product| OR 319937007 |Bezafibrate-containing product| OR 72824008 |Colestyramine| OR 77035009 |Clofibrate| OR 66971004 |Colestipol-containing product| OR 408041006 |Ezetimibe| OR 35282000 |Gemfibrozil| OR 63639004 |Nicotinic acid|) ) OR (&lt;&lt;^ 929360081000036101|MPP Refset|: { 774160008 | Contains clinical drug (attribute) | = &lt;&lt; (108600003 |Atorvastatin| OR 96307003 |Fluvastatin| OR 96305006 |Pravastatin| OR 96304005 |Simvastatin| OR 319982006 |Acipimox-containing product| OR 319937007 |Bezafibrate-containing product| OR 72824008 |Colestyramine| OR 77035009 |Clofibrate| OR 66971004 |Colestipol-containing product| OR 408041006 |Ezetimibe| OR 35282000 |Gemfibrozil| OR 63639004 |Nicotinic acid|) } ) ) .774158006 |Has product name|)) ) ) MINUS ( ( ((&lt;&lt; 1145021005 |Vitamin-containing product|) OR (&lt;&lt;^ 929360081000036101|MPP|: { 774160008|Contains clinical drug| = &lt;&lt; 1145021005 |Vitamin-containing product| }) OR (( ( &lt;&lt; 1145021005 |Vitamin-containing product| ) OR (&lt;&lt;^ 929360081000036101|MPP|: { 774160008|Contains clinical drug| = &lt;&lt; 1145021005 |Vitamin-containing product| } ) ) .774158006 |Has product name|)) ) )</li></ul></div>"
      },
      "url" : "https://www.cvdcheck.org.au/fhir/ValueSet/AusCVDRiskLipidModifyingMedicine-1",
      "version" : "Iteration3",
      "name" : "AusCVDRiskLipidModifyingMedicine",
      "title" : "Aus CVD Risk Lipid Modifying Medicine",
      "status" : "draft",
      "experimental" : false,
      "date" : "2025-05-19T11:57:09+10:00",
      "publisher" : "National Heart Foundation of Australia",
      "contact" : [
        {
          "name" : "National Heart Foundation of Australia",
          "telecom" : [
            {
              "system" : "url",
              "value" : "https://www.heartfoundation.org.au/"
            }
          ]
        }
      ],
      "description" : "The Aus CVD Risk Lipid Modifying Medicine value set includes Australian Medicines Terminology products classified as lipid modifying according to the Australian guideline for assessing and managing cardiovascular disease risk.",
      "jurisdiction" : [
        {
          "coding" : [
            {
              "system" : "urn:iso:std:iso:3166",
              "code" : "AU",
              "display" : "Australia"
            }
          ]
        }
      ],
      "copyright" : "Copyright © 2024+ National Heart Foundation of Australia - All rights reserved. This content is not available under an open source licence.",
      "compose" : {
        "include" : [
          {
            "system" : "http://snomed.info/sct",
            "version" : "http://snomed.info/sct/32506021000036107",
            "filter" : [
              {
                "property" : "constraint",
                "op" : "=",
                "value" : "( ( ((^929360061000036106|MP | AND << (108600003 |Atorvastatin| OR 96307003 |Fluvastatin| OR 96305006 |Pravastatin| OR 96304005 |Simvastatin| OR 319982006 |Acipimox-containing product| OR 319937007 |Bezafibrate-containing product| OR 72824008 |Colestyramine| OR 77035009 |Clofibrate| OR 66971004 |Colestipol-containing product| OR 408041006 |Ezetimibe| OR 35282000 |Gemfibrozil| OR 63639004 |Nicotinic acid|)) OR (<<^929360071000036103|MPUU | AND << (108600003 |Atorvastatin| OR 96307003 |Fluvastatin| OR 96305006 |Pravastatin| OR 96304005 |Simvastatin| OR 319982006 |Acipimox-containing product| OR 319937007 |Bezafibrate-containing product| OR 72824008 |Colestyramine| OR 77035009 |Clofibrate| OR 66971004 |Colestipol-containing product| OR 408041006 |Ezetimibe| OR 35282000 |Gemfibrozil| OR 63639004 |Nicotinic acid|)) OR (<<^ 929360081000036101|MPP Refset|: { 774160008 | Contains clinical drug (attribute) | = << (108600003 |Atorvastatin| OR 96307003 |Fluvastatin| OR 96305006 |Pravastatin| OR 96304005 |Simvastatin| OR 319982006 |Acipimox-containing product| OR 319937007 |Bezafibrate-containing product| OR 72824008 |Colestyramine| OR 77035009 |Clofibrate| OR 66971004 |Colestipol-containing product| OR 408041006 |Ezetimibe| OR 35282000 |Gemfibrozil| OR 63639004 |Nicotinic acid|) }) OR (( ( <<^929360071000036103|MPUU | AND << (108600003 |Atorvastatin| OR 96307003 |Fluvastatin| OR 96305006 |Pravastatin| OR 96304005 |Simvastatin| OR 319982006 |Acipimox-containing product| OR 319937007 |Bezafibrate-containing product| OR 72824008 |Colestyramine| OR 77035009 |Clofibrate| OR 66971004 |Colestipol-containing product| OR 408041006 |Ezetimibe| OR 35282000 |Gemfibrozil| OR 63639004 |Nicotinic acid|) ) OR (<<^ 929360081000036101|MPP Refset|: { 774160008 | Contains clinical drug (attribute) | = << (108600003 |Atorvastatin| OR 96307003 |Fluvastatin| OR 96305006 |Pravastatin| OR 96304005 |Simvastatin| OR 319982006 |Acipimox-containing product| OR 319937007 |Bezafibrate-containing product| OR 72824008 |Colestyramine| OR 77035009 |Clofibrate| OR 66971004 |Colestipol-containing product| OR 408041006 |Ezetimibe| OR 35282000 |Gemfibrozil| OR 63639004 |Nicotinic acid|) } ) ) .774158006 |Has product name|)) ) ) MINUS ( ( ((<< 1145021005 |Vitamin-containing product|) OR (<<^ 929360081000036101|MPP|: { 774160008|Contains clinical drug| = << 1145021005 |Vitamin-containing product| }) OR (( ( << 1145021005 |Vitamin-containing product| ) OR (<<^ 929360081000036101|MPP|: { 774160008|Contains clinical drug| = << 1145021005 |Vitamin-containing product| } ) ) .774158006 |Has product name|)) ) )"
              }
            ]
          }
        ]
      }
    }